A list of recently published and updated articles regarding medical device regulatory updates from the governing bodies throughout Asia.

New Office Space for Asia Actual India

Asia Actual is excited to announce the dedication of our new office space in the Delhi area.  

New Regulations in India Raise the Bar for Many IVD Devices

The new Medical Device Rules, 2017 that took effect January 1, 2018 significantly expands the number of IVD devices requiring full technical documentation in support of their Import License applications.

Philippines FDA Moves to Streamline Submission Systems for Device Registration and Licensing

This month, the Center for Device Regulation, Radiological Health and Research (CDRRHR) has relocated from the Department of Health in Manila to new facilities within the FDA central compound in Alabang.

The Philippines Appoints New FDA Director General

President Rodrigo Duterte appointed Charade Galang-Puno as the new Director General of the Philippines Food and Drug Administration. Dr. Galang-Puno is one of 42 appointees sworn in on Monday, August 15 at the Malacañang Palace in Manila.

The Philippines FDA No Longer Requires Physical Samples for Medical Device Registration

India to Regulate More Medical Devices

At the May 16th Drugs Technical Advisory Board (DTAB) meeting, a resolution passed that expands the list of notified medical devices requiring registration with the Central Drugs Standards Control Organization (CDSCO) in India. The following device categories are affected:

The Philippines FDA Publishes New Guidance on Medical Device Recalls

The Philippines Food and Drug Administration (FDA) has published a Circular clarifying medical device recall requirements referenced in sections 5 (k) of the FDA Act of 2009. The requirements will go into effect in September of 2016.

India Sets Price Limits for Coronary Stents (other devices to follow)

India’s National Pharmaceutical Pricing Authority (NPPA) moved swiftly and sharply to set the Maximum Retail Price (MRP) for coronary stents at INR7,260 (US$105) for bare metal stents and INR29,600 (US$440) for drug eluting stents and bioresorbable vascular scaffolds. T